Diabetes Devices Market Share Sales, Production, And Forecast to 2026
The cost-effectiveness of devices
such as lancets, self-monitoring blood glucose meters, testing strips, and
continuous monitoring devices is completely influencing revenue of the market.
Major international market players are involving themselves in various
collaborations, partnerships and acquisitions to give further rise to the
diabetes device market in the forthcoming years.
Moreover, multiplying prevalence
of diabetes, rising awareness regarding diabetes care, growing intensity of
obesity and technological progressions are further fueling the market growth of
diabetes devices. According to WHO, over 1.9 billion people were identified to
be overweight, of which, around 600 million people were obese. Obese population
are likely to be detected with type 1, type 2 or gestational diabetes. This
information helps us to understand that diabetes market is growing at an
increasing rate due to market drivers mentioned above.
To identify the key trends in the industry, click on the
link below: https://www.reportsanddata.com/report-detail/diabetes-device-market
Key findings from the
report
- Asia-Pacific is anticipated to grow enormously at
CAGR of 8.2% during the forecast period, owing to factors, such as a high
prevalence of diabetes, growing obese population, and government
initiatives of raising awareness regarding diabetic care
- Medtronic PLC received the US Food and Drug
Administration (FDA) approval for Guardian (TM) Connect continuous glucose
monitoring (CGM) system, for people with diabetes aged between 14-75
years. such market initiatives are proving to be profitable for the growth
of diabetes device market
- Glucose monitoring devices dominated the diabetes
devices market by registering 52% of market share in diabetes device
products
- Expansion of the global diabetes management devices
market is also supported by prominent investments, scope of infiltration
in middle- and low-income regions and increasing awareness in patient
population about effective diabetes control and thus preclusion of disease
related complications
- Opportunities for global diabetes device market are
adding up due to development of artificial pancreas and development of
home infusion therapy. Major market players are developing products that
designed to instrument glucose monitoring technologies
- North America is leading the regional market,
followed by Europe owing to higher number of obese individuals, advanced
healthcare infrastructure, availability of technologically advanced
products and overall health consciousness.
- The National Healthcare System will expect children
with 12 years of age on an insulin pump to gain sufficient diabetes
control as a result of being on an insulin pump
- Eli Lilly and Sanofi have strategic research projects
to develop Glucose Responsive Insulins (GRIs). GRIs are insulins
which automatically activate or deactivate in response to changing glucose
levels in the blood. They improve diabetes treatment efficacy and reduce
the incidence of hyperglycemia and hypoglycemia.
Request For Free PDF Sample Of This
Research Report At: https://www.reportsanddata.com/sample-enquiry-form/1488
Type (Revenue in USD
Million; 2016–2026)
- Glucose Monitoring Devices
- Self- monitoring blood glucose meters
- Blood glucose testing strips
- Lancets
- Continuous glucose monitoring meters
- Insulin Delivery Devices
- Insulin syringes
- Insulin pens
- Insulin pumps
- Diabetes Management Software
- Artificial Pancreas System
Distribution
Channels (Revenue in USD Million; 2016–2026)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Diabetes Clinics/ Centers
- Others
Regional Outlook (Revenue in
USD Million; 2016–2026)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of the Europe
- Asia Pacific
- China
- India
- Japan
- Rest of Asia-Pacific
- Middle East & Africa
- Latin America
- Brazil
Comments
Post a Comment